These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27906748)

  • 1. Evolving therapies for hepatitis C virus in chronic kidney disease: the beginning of a new era.
    Gordon CE; Nader C
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):129-135. PubMed ID: 27906748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.
    Mendizabal M; Reddy KR
    J Viral Hepat; 2017 Jun; 24(6):442-453. PubMed ID: 28107583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective.
    Jadoul M; Martin P
    Blood Purif; 2017; 43(1-3):206-209. PubMed ID: 28114144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis c virus and chronic kidney disease.
    Khan MU; Mahmoud MI; Butt AA
    Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):579-590. PubMed ID: 32613874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
    Fabrizi F; Martin P; Messa P
    Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Transplantation From Hepatitis C Virus-Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update.
    Gordon CE; Adam GP; Jadoul M; Martin P; Balk EM
    Am J Kidney Dis; 2023 Oct; 82(4):410-418. PubMed ID: 37061019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in hepatitis C virus management in chronic kidney disease.
    Cohen-Bucay A; Francis JM; Gordon CE
    Curr Opin Nephrol Hypertens; 2021 Sep; 30(5):493-500. PubMed ID: 34054074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals.
    Ko SY; Choe WH
    Clin Mol Hepatol; 2018 Dec; 24(4):351-357. PubMed ID: 29544240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease.
    Elmowafy AY; Abbas MH; Denewar AA; Mashaly ME; Shiha G; El Wasif SM; Rostaing L; Bakr MA
    Int Urol Nephrol; 2021 Apr; 53(4):749-761. PubMed ID: 33111161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting.
    Beinhardt S; Al Zoairy R; Ferenci P; Kozbial K; Freissmuth C; Stern R; Stättermayer AF; Stauber R; Strasser M; Zoller H; Watschinger B; Schmidt A; Trauner M; Hofer H; Maieron A
    Transpl Int; 2016 Sep; 29(9):999-1007. PubMed ID: 27203857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-Acting Antiviral Agents for the Hepatitis C Virus-Infected Chronic Kidney Disease Population: The Dawn of a New Era.
    Kusnir J; Roth D
    Semin Dial; 2016; 29(1):5-6. PubMed ID: 26781743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.
    Kim SM; Song IH
    Korean J Intern Med; 2018 Jul; 33(4):670-678. PubMed ID: 29961309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sustained virologic response in patients with hepatitis C and chronic kidney disease].
    Jasso-Baltazar EA; Solís-Galindo FA; Muñoz-Hernández MA; Quintal-Medina IA
    Rev Med Inst Mex Seguro Soc; 2022 May; 60(3):283-288. PubMed ID: 35763028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline.
    Awan AA; Jadoul M; Martin P
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2158-2167. PubMed ID: 31376491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
    García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
    Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C and Treatment in Patients with Chronic Kidney Disease.
    Jalota A; Lindner BK; Thomas B; Lerma EV
    Dis Mon; 2021 Feb; 67(2):101017. PubMed ID: 32553421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
    Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
    PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct-acting antiviral agents, hepatitis C and dialysis: an update].
    Fabrizi F; Lampertico P; Messa P
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and management options for the hepatitis C virus infected kidney transplant candidate.
    Dejman A; Ladino MA; Roth D
    Hemodial Int; 2018 Apr; 22 Suppl 1():S36-S44. PubMed ID: 29694726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
    Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
    Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.